MisophoniaNCT06785649
The Efficacy of Lavender Herbal Tea in Misophonia
A study testing Lavender herbal tea in people with Misophonia and Misophonia Treatment, run by Sakarya University.
Trial summary
Misophonia is a disorder characterized by a high level of annoyance with certain sounds. Exposure to these sounds causes physical symptoms characterized by anger, aggression, helplessness, overwhelm, and stimulation of the sympathetic nervous system. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Misophonia, Misophonia Treatment, Anxiety
- What is being tested?
- Lavender herbal tea
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 1 Feb 2025to 28 Feb 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Reporting at least three trigger sounds
- Assessed by a specialist psychiatric nurse and a psychiatrist as humophonia based on the diagnostic criteria for humophonia established by Schröder et al. (2013)
- Individuals aged 18 and over
Who cannot join
- Allergy to any herbal tea, food or medicine
- Psychiatric illness or chronic illness
- Taking psychiatric medication (such as anxiolytics, and antidepressants)
- Regular use of medication (such as antihypertensive, antidiabetic)
- Regular use of herbal teas or complementary medicines
- Tinnitus and/or hyperacusis
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Effect of Lavender Herbal Tea on the Mental Health of Individuals With Misophonia: A Randomized Clinical Trial
Misophonia is a disorder characterized by a high level of annoyance with certain sounds. Exposure to these sounds causes physical symptoms characterized by anger, aggression, helplessness, overwhelm, and stimulation of the sympathetic nervous system. These emotional and physical reactions can lead to a decline in family relationships, work and school productivity, withdrawal from social relationships, and even suicide. There is limited empirical evidence evaluating the efficacy of therapeutic approaches to misophonia. This limited empirical evidence consists of pharmacological agents such as selective serotonin reuptake inhibitors, stimulants, antipsychotics, and β-Blockers, as well as cognitive behavioral therapy, acceptance and commitment therapy, and dialectical behavior therapy. Complementary therapies are important because of their potential efficacy, tolerability, possible non-interference, and low cost. The fact that lavender has anxiolytic, antidepressant, neuroprotective, and anti-inflammatory properties may affect the emotional and physical responses elicited by misophonia. Therefore, within the scope of the study, misophonia individuals will be divided into two groups; one group will use lavender tea for 14 days and the other group will form a waiting list. The study data will be collected by 'Information Collection Form', 'Misophonia Scale', 'Beck Depression Inventory-II', 'Anxiety Rating Scale', and 'Trait Anger Scale'. SPSS 25.0 software will be used to analyze the data obtained from the research. Considering the limitations of therapeutic approaches for misophonia, testing the effectiveness of lavender in reducing misophonia symptoms will make an important contribution to the literature.
Read the detailed description
Misophonia is a disorder of vocal sensitivity characterized by unusual discomfort with certain sounds. Typical triggers are sounds produced by humans, particularly oral and nasal sounds. These sounds include chewing, slurping, breathing, keyboard sounds, or pen clicks. When individuals with misophonia are exposed to triggers, stimulation of the sympathetic nervous system and emotional distress are observed. Exposure to triggers creates irritation, desire to avoid stimuli, anger, aggression, helplessness, and overwhelm. Stimulation of the sympathetic nervous system leads to physical symptoms such as hypertonia, sweating, and tachycardia. The discomfort and stress caused by misophonia can lead to increased anxiety levels in individuals. At the same time, the emotional distress and discomfort associated with misophonia can trigger depressive symptoms and increase the risk of depression. Concomitant anxiety and depression can worsen the existing symptoms of misophonia and lead to a reduced quality of life.
There is limited empirical evidence evaluating the efficacy of therapeutic approaches to misophonia. Current treatment approaches include cognitive behavioral therapy, acceptance and commitment therapy, and psychotherapies derived from dialectical behavior therapy. Due to the small number of randomized controlled trials, the efficacy of the protocols used in the treatment of misophonia remains unclear. Due to limited resources, problems such as limited access to psychotherapies and early withdrawal from treatment are also observed. Other treatment approaches include pharmacological agents such as selective serotonin reuptake inhibitors (SSRIs), stimulants, antipsychotics, and β-Blockers. Complementary therapies are used due to their potential efficacy, tolerability, possible non-interference, and low cost. Lavender, a complementary treatment intervention, is considered to have anxiolytic, antidepressant, neuroprotective, and anti-inflammatory properties. Lavender is known to positively affect memory, provide alertness, and improve feelings of well-being. Thus, it is seen as an effective herbal medicine intervention in reducing anxiety and depression. Reducing concomitant anxiety and depression may contribute to the improvement of the symptoms of misophonia.
- Conditions
- Misophonia, Misophonia Treatment, Anxiety, Depression, Anger, Complementary Medicine
- Being tested
- Lavender herbal tea
- Keywords
- misophonia, anxiety, depression, anger, lavender
- Medical subject headings
- misophonia, Anxiety Disorders, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lavender herbal teaOther
The participant will be allocated 14 pieces of lavender tea bags consisting of 2 grams and originating from Turkey. During 14 days, the participant will be advised to use 2 g of lavender herb brewed in 300 mL hot water for 10-15 minutes in the morning and evening. Participants will be able to use 1 lavender tea bag twice a day.
| Study group | Role | What they receive |
|---|---|---|
| Experimental group (lavender herbal tea) | Experimental | Each participant will be allocated 14 pieces of lavender tea bags of 2 grams, originating from Turkey. The intervention group will be advised to use 2 g of lavender herb infused in 300 mL hot water for 10-15 minutes in the morning and evening for 14 days. Participants will be advised to take some time and inhale the scent before drinking the herbal tea. Receives: Other: Lavender herbal tea |
| Control group (wait-list) | No intervention | No intervention will be applied to the control group for 14 days. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Misophonia Scale
It is a 30-item self-report scale aiming to assess the severity of misophonia. The scale is a 5-point Likert-type scale and is graded between 1: Strongly agree and 5: Strongly disagree to 5: Strongly disagree. The total score range is 30 - 150. As the score obtained from the scale decreases, the level of misophonia severity decreases.
Measured: Within the first 24 hours after 14 days of lavender tea
Secondary outcomes (3)
Beck Depression Inventory-II (BDI-II)
It is a 21-item self-report inventory aimed at assessing the severity of depression. The items are rated from 0 to 3 depending on the severity of symptoms. The total score range is 0 to 63 and is divided into four grades in terms of severity: minimal depression (total score 0-13), mild depression (14-19), moderate depression (20-28) and severe depression (≥ 29).
Measured: Within the first 24 hours after 14 days of lavender tea
Anxiety Assessment Scale
This scale, which evaluates anxiety, consists of 10 items. The scale is in 5-point Likert type and is expressed as 1: Never, 2: Very Rarely, 3: Sometimes, 4: Often, 5: Almost Always. There are no reverse scored items in the scale, the total scale score of anxiety is obtained by summing all items. The lowest score that can be obtained from the scale is 10 and the highest score is 50. The higher the total score, the higher the level of anxiety.
Measured: Within the first 24 hours after 14 days of lavender tea
Trait Anger Scale (SL-Anger)
This scale is an assessment tool that measures how often and at what level individuals feel anger in their lives. Consisting of 10 items, this test is graded with a four-point Likert type (1=Never, 2=Sometimes, 3=Most of the time, 4=Always). The increase in the total score obtained from the scale indicates that the individual tends to feel anger more frequently and more intensely in his/her life.
Measured: Within the first 24 hours after 14 days of lavender tea
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jan 2025
- Study start1 Feb 2025 (estimated)
- Primary completion1 Feb 2025 (estimated)
- Study completion28 Feb 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (12)Papers the sponsor has linked to this study.
- Other trials for MisophoniaStudies of the same condition, open and under way.
- More trials run by Sakarya UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The waiting list group, which is the control group, will not undergo any intervention. The experimental group will use lavender herbal tea in the morning and evening for 14 days.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sakarya University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06785649
- Sponsor's protocol ID
- 3-1-2024-SK
- Status last verified
- Jan 2025
- First submitted
- 4 Jan 2025
- Last updated
- 21 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kianpour M, Moshirenia F, Kheirabadi G, Asghari G, Dehghani A, Dehghani-Tafti A. The Effects of Inhalation Aromatherapy with Rose and Lavender at Week 38 and Postpartum Period on Postpartum Depression in High-risk Women Referred to Selected Health Centers of Yazd, Iran in 2015. Iran J Nurs Midwifery Res. 2018 Sep-Oct;23(5):395-401. doi: 10.4103/ijnmr.IJNMR_116_16.
PubMed 30186346Firoozeei TS, Feizi A, Rezaeizadeh H, Zargaran A, Roohafza HR, Karimi M. The antidepressant effects of lavender (Lavandula angustifolia Mill.): A systematic review and meta-analysis of randomized controlled clinical trials. Complement Ther Med. 2021 Jun;59:102679. doi: 10.1016/j.ctim.2021.102679. Epub 2021 Feb 4.
PubMed 33549687Su S, Wang Y, Jiang W, Zhao W, Gao R, Wu Y, Tao J, Su Y, Zhang J, Li K, Zhang Z, Zhao M, Wang Z, Luo Y, Huang X, Wang L, Wang X, Li Y, Jia Q, Wang L, Li H, Huang J, Qiu J, Xu Y. Efficacy of Artificial Intelligence-Assisted Psychotherapy in Patients With Anxiety Disorders: A Prospective, National Multicenter Randomized Controlled Trial Protocol. Front Psychiatry. 2022 Jan 20;12:799917. doi: 10.3389/fpsyt.2021.799917. eCollection 2021.
PubMed 35126211Rappoldt LR, van der Pol MM, de Wit C, Slaghekke S, Houben C, Sondaar T, Kan KJ, van Steensel FJAB, Denys D, Vulink NCC, Utens EMWJ. Effectiveness of an innovative treatment protocol for misophonia in children and adolescents: Design of a randomized controlled trial. Contemp Clin Trials Commun. 2023 Mar 11;33:101105. doi: 10.1016/j.conctc.2023.101105. eCollection 2023 Jun.
PubMed 36950304Jager IJ, Vulink NCC, Bergfeld IO, van Loon AJJM, Denys DAJP. Cognitive behavioral therapy for misophonia: A randomized clinical trial. Depress Anxiety. 2020 Dec 18;38(7):708-18. doi: 10.1002/da.23127. Online ahead of print.
PubMed 33336858Cowan, E. N., Marks, D. R., & Pinto, A. Misophonia: A psychological model and proposed treatment. Journal of Obsessive-Compulsive and Related Disorders, 32, 100691. https://doi.org/10.1016/j.jocrd.2021.100691
Jager I, de Koning P, Bost T, Denys D, Vulink N. Misophonia: Phenomenology, comorbidity and demographics in a large sample. PLoS One. 2020 Apr 15;15(4):e0231390. doi: 10.1371/journal.pone.0231390. eCollection 2020.
PubMed 32294104Cassiello-Robbins C, Anand D, McMahon K, Brout J, Kelley L, Rosenthal MZ. A Preliminary Investigation of the Association Between Misophonia and Symptoms of Psychopathology and Personality Disorders. Front Psychol. 2021 Jan 14;11:519681. doi: 10.3389/fpsyg.2020.519681. eCollection 2020.
PubMed 33519567Erfanian M, Kartsonaki C, Keshavarz A. Misophonia and comorbid psychiatric symptoms: a preliminary study of clinical findings. Nord J Psychiatry. 2019 May-Jul;73(4-5):219-228. doi: 10.1080/08039488.2019.1609086. Epub 2019 May 8.
PubMed 31066600Brout JJ, Edelstein M, Erfanian M, Mannino M, Miller LJ, Rouw R, Kumar S, Rosenthal MZ. Investigating Misophonia: A Review of the Empirical Literature, Clinical Implications, and a Research Agenda. Front Neurosci. 2018 Feb 7;12:36. doi: 10.3389/fnins.2018.00036. eCollection 2018.
PubMed 29467604Swedo SE, Baguley DM, Denys D, Dixon LJ, Erfanian M, Fioretti A, Jastreboff PJ, Kumar S, Rosenthal MZ, Rouw R, Schiller D, Simner J, Storch EA, Taylor S, Werff KRV, Altimus CM, Raver SM. Consensus Definition of Misophonia: A Delphi Study. Front Neurosci. 2022 Mar 17;16:841816. doi: 10.3389/fnins.2022.841816. eCollection 2022.
PubMed 35368272Koroglu Gokbel S, Durat G. The effect of lavender herbal tea on the mental health of individuals with misophonia: A randomized controlled trial. J Psychiatr Res. 2026 Apr;195:39-46. doi: 10.1016/j.jpsychires.2026.01.028. Epub 2026 Jan 21.
PubMed 41579454
Study at a glance
From the registry record, last updated by the sponsor on 21 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Lavender Herbal Tea on the Mental Health of Individuals With Misophonia: A Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT06785649
- Acronym / sponsor ID
- 3-1-2024-SK
- Conditions
- Misophonia, Misophonia Treatment, Anxiety, Depression, Anger, Complementary Medicine
- Keywords
- misophonia, anxiety, depression, anger, lavender
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Sakarya UniversityUniversity, hospital or other
- Study start
- 1 Feb 2025 (estimated)
- Primary completion
- 1 Feb 2025 (estimated)
- Study completion
- 28 Feb 2025 (estimated)
- First posted
- 21 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Misophonia is a disorder characterized by a high level of annoyance with certain sounds. Exposure to these sounds causes physical symptoms characterized by anger, aggression, helplessness, overwhelm, and stimulation of the sympathetic nervous system. These emotional and physical reactions can lead to a decline in family relationships, work and school productivity, withdrawal from social relationships, and even suicide. There is limited empirical evidence evaluating the efficacy of therapeutic approaches to misophonia. This limited empirical evidence consists of pharmacological agents such as selective serotonin reuptake inhibitors, stimulants, antipsychotics, and β-Blockers, as well as cognitive behavioral therapy, acceptance and commitment therapy, and dialectical behavior therapy. Complementary therapies are important because of their potential efficacy, tolerability, possible non-interference, and low cost. The fact that lavender has anxiolytic, antidepressant, neuroprotective, and anti-inflammatory properties may affect the emotional and physical responses elicited by misophonia. Therefore, within the scope of the study, misophonia individuals will be divided into two groups; one group will use lavender tea for 14 days and the other group will form a waiting list. The study data will be collected by 'Information Collection Form', 'Misophonia Scale', 'Beck Depression Inventory-II', 'Anxiety Rating Scale', and 'Trait Anger Scale'. SPSS 25.0 software will be used to analyze the data obtained from the research. Considering the limitations of therapeutic approaches for misophonia, testing the effectiveness of lavender in reducing misophonia symptoms will make an important contribution to the literature.
Detailed description
Misophonia is a disorder of vocal sensitivity characterized by unusual discomfort with certain sounds. Typical triggers are sounds produced by humans, particularly oral and nasal sounds. These sounds include chewing, slurping, breathing, keyboard sounds, or pen clicks. When individuals with misophonia are exposed to triggers, stimulation of the sympathetic nervous system and emotional distress are observed. Exposure to triggers creates irritation, desire to avoid stimuli, anger, aggression, helplessness, and overwhelm. Stimulation of the sympathetic nervous system leads to physical symptoms such as hypertonia, sweating, and tachycardia. The discomfort and stress caused by misophonia can lead to increased anxiety levels in individuals. At the same time, the emotional distress and discomfort associated with misophonia can trigger depressive symptoms and increase the risk of depression. Concomitant anxiety and depression can worsen the existing symptoms of misophonia and lead to a reduced quality of life.
There is limited empirical evidence evaluating the efficacy of therapeutic approaches to misophonia. Current treatment approaches include cognitive behavioral therapy, acceptance and commitment therapy, and psychotherapies derived from dialectical behavior therapy. Due to the small number of randomized controlled trials, the efficacy of the protocols used in the treatment of misophonia remains unclear. Due to limited resources, problems such as limited access to psychotherapies and early withdrawal from treatment are also observed. Other treatment approaches include pharmacological agents such as selective serotonin reuptake inhibitors (SSRIs), stimulants, antipsychotics, and β-Blockers. Complementary therapies are used due to their potential efficacy, tolerability, possible non-interference, and low cost. Lavender, a complementary treatment intervention, is considered to have anxiolytic, antidepressant, neuroprotective, and anti-inflammatory properties. Lavender is known to positively affect memory, provide alertness, and improve feelings of well-being. Thus, it is seen as an effective herbal medicine intervention in reducing anxiety and depression. Reducing concomitant anxiety and depression may contribute to the improvement of the symptoms of misophonia.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- The waiting list group, which is the control group, will not undergo any intervention. The experimental group will use lavender herbal tea in the morning and evening for 14 days.
| Arm | Type | Receives |
|---|---|---|
| Experimental group (lavender herbal tea) | Experimental | Other: Lavender herbal teaEach participant will be allocated 14 pieces of lavender tea bags of 2 grams, originating from Turkey. The intervention group will be advised to use 2 g of lavender herb infused in 300 mL hot water for 10-15 minutes in the morning and evening for 14 days. Participants will be advised to take some time and inhale the scent before drinking the herbal tea. |
| Control group (wait-list) | No intervention | –No intervention will be applied to the control group for 14 days. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Reporting at least three trigger sounds
- Assessed by a specialist psychiatric nurse and a psychiatrist as humophonia based on the diagnostic criteria for humophonia established by Schröder et al. (2013)
- Individuals aged 18 and over
Key exclusion criteria (6 listed)
- Allergy to any herbal tea, food or medicine
- Psychiatric illness or chronic illness
- Taking psychiatric medication (such as anxiolytics, and antidepressants)
- Regular use of medication (such as antihypertensive, antidiabetic)
- Regular use of herbal teas or complementary medicines
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lavender herbal teaThe participant will be allocated 14 pieces of lavender tea bags consisting of 2 grams and originating from Turkey. During 14 days, the participant will be advised to use 2 g of lavender herb brewed in 300 mL hot water for 10-15 minutes in the morning and evening. Participants will be able to use 1 lavender tea bag twice a day. | Other | Experimental group (lavender herbal tea) |
Primary outcome
Misophonia Scale
Time frame: Within the first 24 hours after 14 days of lavender tea
It is a 30-item self-report scale aiming to assess the severity of misophonia. The scale is a 5-point Likert-type scale and is graded between 1: Strongly agree and 5: Strongly disagree to 5: Strongly disagree. The total score range is 30 - 150. As the score obtained from the scale decreases, the level of misophonia severity decreases.
3 secondary outcomes
Beck Depression Inventory-II (BDI-II)
Time frame: Within the first 24 hours after 14 days of lavender tea
Anxiety Assessment Scale
Time frame: Within the first 24 hours after 14 days of lavender tea
Trait Anger Scale (SL-Anger)
Time frame: Within the first 24 hours after 14 days of lavender tea
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jan 2025.
- Background: PubMed 30186346Kianpour M, Moshirenia F, Kheirabadi G, Asghari G, Dehghani A, Dehghani-Tafti A. The Effects of Inhalation Aromatherapy with Rose and Lavender at Week 38 and Postpartum Period on Postpartum Depression in High-risk Women Referred to Selected Health Centers of Yazd, Iran in 2015. Iran J Nurs Midwifery Res. 2018 Sep-Oct;23(5):395-401. doi: 10.4103/ijnmr.IJNMR_116_16.
- Background: PubMed 33549687Firoozeei TS, Feizi A, Rezaeizadeh H, Zargaran A, Roohafza HR, Karimi M. The antidepressant effects of lavender (Lavandula angustifolia Mill.): A systematic review and meta-analysis of randomized controlled clinical trials. Complement Ther Med. 2021 Jun;59:102679. doi: 10.1016/j.ctim.2021.102679. Epub 2021 Feb 4.
- Background: PubMed 35126211Su S, Wang Y, Jiang W, Zhao W, Gao R, Wu Y, Tao J, Su Y, Zhang J, Li K, Zhang Z, Zhao M, Wang Z, Luo Y, Huang X, Wang L, Wang X, Li Y, Jia Q, Wang L, Li H, Huang J, Qiu J, Xu Y. Efficacy of Artificial Intelligence-Assisted Psychotherapy in Patients With Anxiety Disorders: A Prospective, National Multicenter Randomized Controlled Trial Protocol. Front Psychiatry. 2022 Jan 20;12:799917. doi: 10.3389/fpsyt.2021.799917. eCollection 2021.
- Background: PubMed 36950304Rappoldt LR, van der Pol MM, de Wit C, Slaghekke S, Houben C, Sondaar T, Kan KJ, van Steensel FJAB, Denys D, Vulink NCC, Utens EMWJ. Effectiveness of an innovative treatment protocol for misophonia in children and adolescents: Design of a randomized controlled trial. Contemp Clin Trials Commun. 2023 Mar 11;33:101105. doi: 10.1016/j.conctc.2023.101105. eCollection 2023 Jun.
- Background: PubMed 33336858Jager IJ, Vulink NCC, Bergfeld IO, van Loon AJJM, Denys DAJP. Cognitive behavioral therapy for misophonia: A randomized clinical trial. Depress Anxiety. 2020 Dec 18;38(7):708-18. doi: 10.1002/da.23127. Online ahead of print.
- BackgroundCowan, E. N., Marks, D. R., & Pinto, A. Misophonia: A psychological model and proposed treatment. Journal of Obsessive-Compulsive and Related Disorders, 32, 100691. https://doi.org/10.1016/j.jocrd.2021.100691
- Background: PubMed 32294104Jager I, de Koning P, Bost T, Denys D, Vulink N. Misophonia: Phenomenology, comorbidity and demographics in a large sample. PLoS One. 2020 Apr 15;15(4):e0231390. doi: 10.1371/journal.pone.0231390. eCollection 2020.
- Background: PubMed 33519567Cassiello-Robbins C, Anand D, McMahon K, Brout J, Kelley L, Rosenthal MZ. A Preliminary Investigation of the Association Between Misophonia and Symptoms of Psychopathology and Personality Disorders. Front Psychol. 2021 Jan 14;11:519681. doi: 10.3389/fpsyg.2020.519681. eCollection 2020.
- Background: PubMed 31066600Erfanian M, Kartsonaki C, Keshavarz A. Misophonia and comorbid psychiatric symptoms: a preliminary study of clinical findings. Nord J Psychiatry. 2019 May-Jul;73(4-5):219-228. doi: 10.1080/08039488.2019.1609086. Epub 2019 May 8.
- Background: PubMed 29467604Brout JJ, Edelstein M, Erfanian M, Mannino M, Miller LJ, Rouw R, Kumar S, Rosenthal MZ. Investigating Misophonia: A Review of the Empirical Literature, Clinical Implications, and a Research Agenda. Front Neurosci. 2018 Feb 7;12:36. doi: 10.3389/fnins.2018.00036. eCollection 2018.
- Background: PubMed 35368272Swedo SE, Baguley DM, Denys D, Dixon LJ, Erfanian M, Fioretti A, Jastreboff PJ, Kumar S, Rosenthal MZ, Rouw R, Schiller D, Simner J, Storch EA, Taylor S, Werff KRV, Altimus CM, Raver SM. Consensus Definition of Misophonia: A Delphi Study. Front Neurosci. 2022 Mar 17;16:841816. doi: 10.3389/fnins.2022.841816. eCollection 2022.
- Derived from this study: PubMed 41579454Koroglu Gokbel S, Durat G. The effect of lavender herbal tea on the mental health of individuals with misophonia: A randomized controlled trial. J Psychiatr Res. 2026 Apr;195:39-46. doi: 10.1016/j.jpsychires.2026.01.028. Epub 2026 Jan 21.
- Individual participant dataSharing planned: No
Related trials for Misophonia
Recruiting
Transcranial Magnetic Stimulation in Misophonia
Misophonia
Not yet recruitingObservational study
Pain, Central Sensitization, and Misophonia in Lipedema
Lipedema
Not yet recruiting
Effectiveness of a Mindfulness-Based Cognitive Behavioral Mobile Intervention for Misophonia
Misophonia, Misophonia Treatment
RecruitingObservational study
Prevalence of Misophonia in Turkish High School Students
Misophonia
RecruitingEarly Phase 1
Propranolol for Misophonia
Misophonia, Propanolol
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Lavender herbal tea in people with Misophonia and Misophonia Treatment, run by Sakarya University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sevgi Koroglu, MSc (05367982320, sevgikoroglu@sakarya.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Misophonia Scale (time frame: Within the first 24 hours after 14 days of lavender tea). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06785649, which also lists 12 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2025.